Clearpoint Neuro Stock Filter Stocks by Fundamentals
CLPT Stock | USD 11.67 0.17 1.44% |
Clearpoint Neuro fundamentals help investors to digest information that contributes to Clearpoint Neuro's financial success or failures. It also enables traders to predict the movement of Clearpoint Stock. The fundamental analysis module provides a way to measure Clearpoint Neuro's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clearpoint Neuro stock.
Clearpoint | Cash and Equivalents |
Clearpoint Neuro Current Valuation Drivers
We derive many important indicators used in calculating different scores of Clearpoint Neuro from analyzing Clearpoint Neuro's financial statements. These drivers represent accounts that assess Clearpoint Neuro's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Clearpoint Neuro's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 63.1M | 251.9M | 232.6M | 204.8M | 167.1M | 83.6M | |
Enterprise Value | 59.9M | 256.0M | 190.8M | 189.2M | 157.9M | 165.8M |
Clearpoint Neuro ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Clearpoint Neuro's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Clearpoint Neuro's managers, analysts, and investors.Environmental | Governance | Social |
Clearpoint Fundamentals
Return On Equity | -0.68 | ||||
Return On Asset | -0.28 | ||||
Profit Margin | (0.60) % | ||||
Operating Margin | (0.64) % | ||||
Current Valuation | 308.59 M | ||||
Shares Outstanding | 27.58 M | ||||
Shares Owned By Insiders | 7.83 % | ||||
Shares Owned By Institutions | 30.53 % | ||||
Number Of Shares Shorted | 687.56 K | ||||
Price To Earning | (3.36) X | ||||
Price To Book | 11.26 X | ||||
Price To Sales | 10.73 X | ||||
Revenue | 23.95 M | ||||
Gross Profit | 13.53 M | ||||
EBITDA | (20.99 M) | ||||
Net Income | (22.09 M) | ||||
Cash And Equivalents | 45.14 M | ||||
Cash Per Share | 1.84 X | ||||
Total Debt | 13.94 M | ||||
Debt To Equity | 0.28 % | ||||
Current Ratio | 10.33 X | ||||
Book Value Per Share | 1.05 X | ||||
Cash Flow From Operations | (13.72 M) | ||||
Short Ratio | 3.36 X | ||||
Earnings Per Share | (0.69) X | ||||
Price To Earnings To Growth | (0.46) X | ||||
Target Price | 16.33 | ||||
Number Of Employees | 107 | ||||
Beta | 1.11 | ||||
Market Capitalization | 326.46 M | ||||
Total Asset | 42.66 M | ||||
Retained Earnings | (172.46 M) | ||||
Working Capital | 28.74 M | ||||
Current Asset | 8.1 M | ||||
Current Liabilities | 1.85 M | ||||
Net Asset | 42.66 M |
About Clearpoint Neuro Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clearpoint Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearpoint Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearpoint Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.